Form 4: Encompass Health Director Receives RSU Dividend Award

Encompass Health Director Kevin J. O'Connor received 14 restricted stock units as part of a common stock dividend payment on October 15, 2025.

Summary

• Kevin J. O'Connor, a Director of Encompass Health Corp. (EHC), acquired 14 Restricted Stock Units (RSUs).
• This acquisition was an award associated with a common stock dividend payment, not a direct purchase.
• The dividend paid was $0.19 per share, and the closing price on the dividend payment date was $123.65.
• Following this transaction, Mr. O'Connor beneficially owns 9,895 shares directly.

Sentiment

Score: 7

Explanation: The transaction reflects a routine award of restricted stock units to a director, aligning their interests with shareholders through increased equity ownership. It is a positive, albeit minor, indication of ongoing director compensation practices and dividend payments.

Positives

• Increased beneficial ownership by a director, aligning management and shareholder interests.
• The company continues to pay dividends, indicating financial stability.

Negatives

• No direct negatives identified in this routine insider transaction filing.

Future Outlook

No specific future outlook or guidance is provided in this transaction report.

Industry Context

This filing reports a routine insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The award of Restricted Stock Units to Director Kevin J. O'Connor is a related party transaction, representing a component of his non-employee director compensation.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders through equity ownership.

Next Steps

• No specific future actions, events, or milestones are mentioned in this filing.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled award of Restricted Stock Units to a non-employee director as part of their compensation and in connection with a dividend payment. It does not contain any new material information that would fundamentally alter the investment thesis for Encompass Health Corp. Therefore, a 'hold' recommendation is appropriate as this transaction alone does not warrant a change in investment strategy.

Keywords

Encompass Health, EHC, Kevin O'Connor, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director, Dividend